- Analysis of Plasma Epstein-Barr Virus DNA to Screen for Nasopharyngeal Cancer.N Engl J Med, 2018, 378(10): 973-973.
- Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein–Barr virus DNA level and tumor response to palliative chemotherapyXue Song Sun; Li Ting Liu; Sai Lan Liu; Shan Shan Guo; Yue Feng Wen; Hao Jun Xie; Qing Nan Tang; Yu Jing Liang; Xiao Yun Li; Jin Jie Yan; Jun Ma; Qiu Yan Chen; Lin Quan Tang; Hai Qiang Mai2019.
- Staging of nasopharyngeal carcinoma - The past, the present and the futureNg Wai Tong; Yuen Kam Tong; Au Kwok Hung; Chan Oscar S H; Lee Anne W MOral Oncology, 2014, 50(6): 549-554.
会议论文
Development of a clinicomolecular risk stratification system for nonmetastatic nasopharyngeal carcinoma using Epstein-Barr virus DNA and TNM stage: A "Big data" analysis of 9,160 endemic cases.
20阅读
